Bausch + Lomb Launches Blink NutriTears for Dry Eye Symptoms

Bausch + Lomb announced the US launch of Blink NutriTears, an over-the-counter supplement designed to target the key root causes of dry eyes, promote healthy tear production, and provide relief of eye dryness symptoms in as little as 2 to 4 weeks.

“We offer dry eye sufferers a wide array of options that target the ocular surface, but many consumers are looking for options that go beyond eye drops,” stated John Ferris, executive vice president, Consumer, Bausch + Lomb, in a company news release. “With Blink NutriTears, consumers now have a first-of-its-kind clinically proven nutritional supplement that helps hydrate their eyes from within and provides long-lasting relief. It will be an outstanding complement to our growing dry eye portfolio.”

The Science Behind Blink NutriTears

Developed in collaboration with eye care and nutritional experts, Blink NutriTears is formulated with a proprietary blend of ingredients, including lutein, zeaxanthin, curcumin, and vitamin D, which were shown to improve ocular symptom severity and tear film homeostasis, according to Bausch + Lomb. It was also shown to clinically help tears stay on the eyes for 33% longer.

Blink NutriTears will be available in the eye care aisle or online at most major retailers nationwide by the end of July.

Understanding Dry Eyes

Dry eyes, a common ocular condition, occur when the eyes fail to produce enough tears or produce tears of poor quality, leading to discomfort and irritation. The symptoms of dry eyes can vary widely, including sensations of dryness, burning, itching, or grittiness in the eyes, as well as excessive tearing, sensitivity to light, and blurred vision. Left untreated, dry eye symptoms can worsen over time and potentially lead to complications that impact overall eye health and vision.

Clinical Study on Blink NutriTears

The prospective, randomized, double-blind, parallel, placebo-controlled clinical study evaluated the efficacy and safety of Blink NutriTears in 155 adult participants with mild dry eye symptoms (aged 18–65; median age 42). Participants were randomized to receive one Blink NutriTears or placebo capsule per day for 56 days (eight weeks). Artificial tear use was also recorded. The clinical study met both of its primary endpoints. Participants consuming the once-daily Blink NutriTears had significant improvements in tear production, and by day 14, total Ocular Surface Disease Index (OSDI) scores, as well as symptoms and vision domains of the OSDI, significantly improved from baseline for participants consuming Blink NutriTears versus placebo.